|کد مقاله||کد نشریه||سال انتشار||مقاله انگلیسی||ترجمه فارسی||نسخه تمام متن|
|5665880||1407775||2017||3 صفحه PDF||سفارش دهید||دانلود کنید|
- Documenting a fungemia case in an immunocompetent patient after administration of probiotic.
- Concluding the Saccharomyces yeast causing the patient bloodstream infection was indeed from the probiotic capsule.
- Demonstrating the usefulness and feasibility of the two commercial-available strain-typing methods: DivsersiLab and MALDI-TOF MS.
- Questioning the safety of this preventative biotherapy in clinical use.
We report a case of fungemia in an immunocompetent patient after administration of probiotic containing Saccharomyces boulardii. We demonstrated the strain relatedness of the yeast from the probiotic capsule and the yeast causing fungal infection using genomic and proteomic typing methods. Our study questions the safety of this preventative biotherapy.
Journal: Diagnostic Microbiology and Infectious Disease - Volume 87, Issue 3, March 2017, Pages 286-288